Current report filing

FAIR VALUE MEASUREMENTS (Tables)

v3.19.2
FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Dec. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Assets and liabilities measured at fair value on a recurring basis
The following tables summarize those assets and liabilities measured at fair value on a recurring basis (in millions):
 
December 31, 2018
 
 
Level 1

Level 2

Level 3

Other3

Netting
Adjustment

4 
Fair Value
Measurements

 
Assets:
 
 
 
 
 
 
 
 
Equity securities with readily determinable values1
$
1,681

$
186

$
6

$
61

$

 
$
1,934

 
Debt securities1

5,018

19



 
5,037

 
     Derivatives2
2

313



(261
)
5 
54

7 
Total assets
$
1,683

$
5,517

$
25

$
61

$
(261
)
 
$
7,025

 
Liabilities:
 
 
 
 
 
 
 
 
    Derivatives2
$
(14
)
$
(221
)
$

$

$
182

6 
$
(53
)
7 
Total liabilities
$
(14
)
$
(221
)
$

$

$
182

 
$
(53
)
 
1 
Refer to Note 4 for additional information related to the composition of our equity securities with readily determinable values and debt securities.
2 
Refer to Note 6 for additional information related to the composition of our derivative portfolio.
3 
Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy but are included to reconcile to the amounts presented in Note 4.
4 
Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative positions and also cash collateral held or placed with the same counterparties. There are no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting requirements. Refer to Note 6.
5 
The Company is obligated to return $96 million in cash collateral it has netted against its derivative position.
6 
The Company has the right to reclaim $4 million in cash collateral it has netted against its derivative position.
7 
The Company's derivative financial instruments are recorded at fair value in our consolidated balance sheet as follows: $54 million in the line item other assets; $3 million in the line item accounts payable and accrued expenses; and $50 million in the line item other liabilities. Refer to Note 6 for additional information related to the composition of our derivative portfolio.











 
December 31, 2017
 
 
Level 1

Level 2

Level 3

 
Other4

Netting
Adjustment

5 
Fair Value
Measurements

 
Assets:
 
 
 
 
 
 
 
 
 
Trading securities1
$
212

$
127

$
3

 
$
65

$

 
$
407

 
Available-for-sale securities1
1,899

5,739

169

3 


 
7,807

 
     Derivatives2
7

250


 

(198
)
6 
59

8 
Total assets
$
2,118

$
6,116

$
172

 
$
65

$
(198
)
 
$
8,273

 
Liabilities:
 
 
 
 
 
 
 
 
 
    Derivatives2
$
(3
)
$
(262
)
$

 
$

$
147

7 
$
(118
)
8 
Total liabilities
$
(3
)
$
(262
)
$

 
$

$
147

 
$
(118
)
 
1 
Refer to Note 4 for additional information related to the composition of our trading securities and available-for-sale securities.
2 
Refer to Note 6 for additional information related to the composition of our derivative portfolio.
3 
Primarily related to debt securities that mature in 2018.
4 
Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy but are included to reconcile to the amounts presented in Note 4.
5 
Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative positions and also cash collateral held or placed with the same counterparties. There are no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting requirements. Refer to Note 6.
6 
The Company is obligated to return $55 million in cash collateral it has netted against its derivative position.
7 
The Company has the right to reclaim $2 million in cash collateral it has netted against its derivative position.
8 
The Company's derivative financial instruments are recorded at fair value in our consolidated balance sheet as follows: $59 million in the line item other assets; $40 million in the line item accounts payable and accrued expenses; and $78 million in the line item other liabilities. Refer to Note 6 for additional information related to the composition of our derivative portfolio.
Assets measured at fair value on a nonrecurring basis
The gains and losses on assets measured at fair value on a nonrecurring basis are summarized in the table below (in millions):
 
Gains (Losses)  
 
Year Ended December 31,
2018

 
2017

 
Other-than-temporary impairment charges
$
(591
)
1 
$
(50
)
5 
CCBA asset adjustments
(554
)
2 

 
Other long-lived assets
(312
)
3 
(329
)
6 
Intangible assets
(138
)
3 
(442
)
7 
Assets held for sale

 
(1,819
)
8 
Investment in formerly unconsolidated subsidiary
(32
)
4 
150

9 
Valuation of shares in equity method investee

 
25

10 
Total
$
(1,627
)
 
$
(2,465
)
 
1 
The Company recognized other-than-temporary impairment charges of $334 million related to certain equity method investees in the Middle East. These impairments were primarily driven by revised projections of future operating results largely related to instability in the region, which include recent sanctions imposed locally. The Company also recognized an other-than-temporary impairment charge of $205 million related to an equity method investee in Indonesia. This impairment was primarily driven by revised projections of future operating results reflecting unfavorable macroeconomic conditions and foreign currency exchange rate fluctuations. Additionally, the
Company recognized an other-than-temporary impairment charge of $52 million related to one of our equity method investees in Latin America. This impairment was primarily driven by revised projections of future operating results. The fair value of each of these investments was derived using discounted cash flow analyses based on Level 3 inputs.
2 
The Company recorded an impairment charge of $554 million related to assets held by CCBA. This charge was incurred primarily as a result of management's view of the proceeds that were expected to be received upon sale based on revised projections of future operating results and foreign currency exchange rate fluctuations. The fair value of these assets was derived using discounted cash flow analyses based on Level 3 inputs. Refer to Note 2 and Note 18.
3 
The Company recognized charges of $312 million related to CCR's property, plant and equipment and $138 million related to CCR's intangible assets. These charges were a result of management's revised estimate of the proceeds that were expected to be received for the remaining bottling territories upon their refranchising. These charges were determined by comparing the fair value of the reporting unit, based on Level 3 inputs, to its carrying value. Refer to Note 18.
4 
The Company recognized a loss of $32 million, which included the remeasurement of our previously held equity interest in the Philippine bottling operations to fair value and the reversal of the related cumulative translation adjustments. The fair value of our previously held equity investment was determined using a discounted cash flow model based on Level 3 inputs.
5 
The Company recognized an other-than-temporary impairment charge of $50 million related to one of our international equity method investees, primarily driven by foreign currency exchange rate fluctuations. The fair value of this investment was derived using discounted cash flow analyses based on Level 3 inputs.
6 
The Company recognized impairment charges of $310 million related to CCR's property, plant and equipment and $19 million related to CCR's other assets primarily as a result of refranchising activities in North America. The fair value of these assets was derived using management's estimate of the proceeds that were expected to be received for the remaining bottling territories upon their refranchising.
7 
The Company recognized an impairment charge of $375 million related to CCR's goodwill. This impairment charge was determined by comparing the fair value of the reporting unit, based on Level 3 inputs, to its carrying value. The Company also recognized an impairment charge of $33 million related to certain U.S. bottlers' franchise rights. This charge was determined by comparing the fair value of the asset to its current carrying value. Each of these impairment charges was primarily a result of refranchising activities in North America and management's estimates of the proceeds that were expected to be received for the remaining bottling territories upon their refranchising. Additionally, the Company recorded impairment charges of $34 million related to Venezuelan intangible assets due to weaker sales and the volatility of foreign currency exchange rates resulting from continued political instability. The fair value of these assets was derived using discounted cash flow analyses based on Level 3 inputs.
8 
The Company is required to record assets and liabilities that are held for sale at the lower of carrying value or fair value less any costs to sell based on the agreed-upon sale price. These losses related to refranchising activities in North America. The charges were calculated based on Level 3 inputs. Refer to Note 2.
9 The Company recognized a gain of $150 million on our previously held equity interests in CCBA and its South African subsidiary, which were accounted for under the equity method of accounting prior to our consolidation of the bottler in October 2017. U.S. GAAP requires the acquirer to remeasure its previously held noncontrolling equity interest in the acquired entity to fair value as of the acquisition date and recognize any gains or losses in earnings. The Company remeasured our equity interests in CCBA and its South African subsidiary based on Level 3 inputs. Refer to Note 2.
10 The Company recognized a gain of $25 million as a result of Coca-Cola FEMSA, an equity method investee, issuing additional shares of
its stock at a per share amount greater than the carrying value of the Company's per share investment. Accordingly, the Company is
required to treat this type of transaction as if the Company had sold a proportionate share of its investment in Coca-Cola FEMSA. This
gain was determined using Level 1 inputs.
Summary of the fair value of pension plan assets for U.S. and non-U.S. pension plans
The following table summarizes the levels within the fair value hierarchy for our pension plan assets (in millions):
 
December 31, 2018
 
December 31, 2017
 
Level 1

Level 2

Level 3

 
Other 1

 
Total

 
Level 1

Level 2

Level 3

 
Other 1

 
Total

Cash and cash equivalents
$
461

$
22

$

 
$

 
$
483

 
$
649

$
65

$

 
$

 
$
714

Equity securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S.-based companies
1,728

15

17

 

 
1,760

 
2,080

3

14

 

 
2,097

International-based companies
1,098

23


 

 
1,121

 
1,465



 

 
1,465

Fixed-income securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Government bonds

463


 

 
463

 

374


 

 
374

Corporate bonds and debt
   securities

819

16

 

 
835

 

803

24

 

 
827

Mutual, pooled and commingled
   funds
46

130


 
699

3 
875

 
239

42


 
700

3 
981

Hedge funds/limited partnerships



 
828

4 
828

 



 
983

4 
983

Real estate



 
391

5 
391

 


2

 
596

5 
598

Other


270

2 
403

6 
673

 


263

2 
564

6 
827

Total
$
3,333

$
1,472

$
303

 
$
2,321

 
$
7,429

 
$
4,433

$
1,287

$
303

 
$
2,843

 
$
8,866

1 
Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy but are included to reconcile to the amounts presented in Note 14.
2 
Includes purchased annuity insurance contracts.
3 
This class of assets includes actively managed emerging markets equity funds and a collective trust fund for qualified plans, invested primarily in equity securities of companies in developed and emerging markets. There are no liquidity restrictions on these investments.
4 
This class of assets includes hedge funds that can be subject to redemption restrictions, ranging from monthly to tri-annually, with a redemption notice period of up to 120 days and/or initial lock-up periods of up to one year, and private equity funds that are primarily closed-end funds in which the Company's investments are generally not eligible for redemption. Distributions from these private equity funds will be received as the underlying assets are liquidated or distributed.
5 
This class of assets includes funds invested in real estate, including a privately held real estate investment trust, a real estate commingled pension trust fund, infrastructure limited partnerships and commingled investment funds. These funds seek current income and capital appreciation through the investments and can be subject to redemption restrictions, ranging from quarterly to semi-annually, with a redemption notice period of up to 90 days.
6 
This class of assets includes segregated portfolios of private investment funds that are invested in a portfolio of insurance-linked securities. These assets can be subject to a semi-annual redemption, with a redemption notice period of 90 days, subject to certain gate restrictions.
Reconciliation of the beginning and ending balance of Level 3 assets for U.S. and non-U.S. pension plans
The following table provides a reconciliation of the beginning and ending balance of Level 3 assets for our U.S. and non-U.S. pension plans (in millions):
 
Equity
Securities

Fixed-Income Securities

Real Estate

Other

 
Total

2017
 
 
 
 
 
 
Balance at beginning of year
$
14

$
19

$
2

$
211

 
$
246

Actual return on plan assets held at the reporting date
(3
)
1


4

 
2

Purchases, sales and settlements — net
3

1


(9
)
 
(5
)
Transfers into/(out of) Level 3 — net

3


31

 
34

Foreign currency translation adjustments



26

 
26

Balance at end of year
$
14

$
24

$
2

$
263

1 
$
303

2018
 
 
 
 
 
 
Balance at beginning of year
$
14

$
24

$
2

$
263

 
$
303

Actual return on plan assets held at the reporting date
(2
)
(1
)

19

 
16

Purchases, sales and settlements — net
3

(7
)
(2
)
1

 
(5
)
Transfers into/(out of) Level 3 — net
2




 
2

Foreign currency translation adjustments



(13
)
 
(13
)
Balance at end of year
$
17

$
16

$

$
270

1 
$
303

1 
Includes purchased annuity insurance contracts.
Summary of the fair value of postretirement benefit plan assets
The following table summarizes the levels within the fair value hierarchy for our other postretirement benefit plan assets (in millions):
 
December 31, 2018
 
December 31, 2017
 
Level 1

Level 2

Other 1

Total

 
Level 1

Level 2

Other 1

Total

Cash and cash equivalents
$
73

$

$

$
73

 
$
78

$

$

$
78

Equity securities:
 
 
 
 
 
 
 
 
 
U.S.-based companies
93



93

 
96



96

International-based companies
7



7

 
8



8

Fixed-income securities:
 
 
 
 
 
 
 
 
 
Government bonds

2


2

 

2


2

Corporate bonds and debt securities

16


16

 

7


7

Mutual, pooled and commingled funds


82

82

 


80

80

Hedge funds/limited partnerships


8

8

 


8

8

Real estate


4

4

 


5

5

Other


4

4

 


4

4

Total
$
173

$
18

$
98

$
289

 
$
182

$
9

$
97

$
288

1 
Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy but are included to reconcile to the amounts presented in Note 14.